Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | calcitonin receptor-like | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | calcitonin receptor-like | 461 aa | 434 aa | 28.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | type A flavoprotein, putative | 0.0518 | 0.3033 | 0.5 |
Onchocerca volvulus | 0.0154 | 0 | 0.5 | |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0836 | 0.5684 | 0.5684 |
Brugia malayi | flavodoxin family protein | 0.0518 | 0.3033 | 0.3033 |
Chlamydia trachomatis | sulfite reductase | 0.0836 | 0.5684 | 1 |
Loa Loa (eye worm) | flavodoxin family protein | 0.0518 | 0.3033 | 0.3033 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.1354 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0672 | 0.4316 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.1354 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0836 | 0.5684 | 0.5684 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.1354 | 1 | 1 |
Trypanosoma brucei | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0518 | 0.3033 | 0.3033 |
Leishmania major | cytochrome P450 reductase, putative | 0.12 | 0.8717 | 0.8717 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.1354 | 1 | 1 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.12 | 0.8717 | 1 |
Mycobacterium tuberculosis | Possible electron transfer protein FdxB | 0.0154 | 0 | 0.5 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0518 | 0.3033 | 0.3033 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.1354 | 1 | 1 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0672 | 0.4316 | 1 |
Mycobacterium tuberculosis | Possible oxygenase | 0.0154 | 0 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.1354 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.1354 | 1 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0518 | 0.3033 | 0.3033 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.1354 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0518 | 0.3033 | 0.3033 |
Trypanosoma cruzi | NADPH--cytochrome P450 reductase, putative | 0.0518 | 0.3033 | 0.3033 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.1354 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0518 | 0.3033 | 0.5 |
Plasmodium falciparum | nitric oxide synthase, putative | 0.1354 | 1 | 1 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0672 | 0.4316 | 0.4316 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.1354 | 1 | 1 |
Leishmania major | p450 reductase, putative | 0.1354 | 1 | 1 |
Mycobacterium tuberculosis | Hypothetical oxidoreductase | 0.0154 | 0 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.1354 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0518 | 0.3033 | 0.5 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.0682 | 0.4402 | 0.4402 |
Mycobacterium tuberculosis | Probable monooxygenase | 0.0154 | 0 | 0.5 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0518 | 0.3033 | 0.5 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.1354 | 1 | 1 |
Trypanosoma cruzi | p450 reductase, putative | 0.1354 | 1 | 1 |
Trypanosoma cruzi | Flavodoxin/Radical SAM superfamily/Wyosine base formation, putative | 0.0518 | 0.3033 | 0.3033 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.1354 | 1 | 1 |
Plasmodium falciparum | S-adenosyl-L-methionine-dependent tRNA 4-demethylwyosine synthase, putative | 0.0518 | 0.3033 | 0.3033 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0154 | 0 | 0.5 |
Giardia lamblia | Hypothetical protein | 0.12 | 0.8717 | 1 |
Plasmodium vivax | flavodoxin domain containing protein | 0.12 | 0.8717 | 0.8717 |
Plasmodium falciparum | NADPH--cytochrome P450 reductase, putative | 0.0518 | 0.3033 | 0.3033 |
Echinococcus multilocularis | methionine synthase reductase | 0.0836 | 0.5684 | 0.5684 |
Trichomonas vaginalis | NADPH fad oxidoreductase, putative | 0.12 | 0.8717 | 0.8159 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.1354 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1354 | 1 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.1354 | 1 | 1 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.1354 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.0836 | 0.5684 | 0.5684 |
Echinococcus granulosus | methionine synthase reductase | 0.0836 | 0.5684 | 0.5684 |
Treponema pallidum | flavodoxin | 0.0518 | 0.3033 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.1354 | 1 | 1 |
Entamoeba histolytica | type A flavoprotein, putative | 0.0518 | 0.3033 | 0.5 |
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.1354 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 0.11 nM | Displacement of [125I]hCGRP from human cloned CGRP receptor expressed in HEK293 cells | ChEMBL. | 20850973 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.